Spots Global Cancer Trial Database for folfirinox
Every month we try and update this database with for folfirinox cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | NCT06203821 | Pancreatic Canc... | NP137 | 18 Years - | University of Rochester | |
| A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | NCT04990037 | Metastatic Panc... | CAN04 FOLFIRINOX | 18 Years - | Cantargia AB | |
| A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | NCT02539537 | Pancreatic Canc... Carcinoma | Gemcitabine Folinic Acid 5-Fluoro-uracil Oxaliplatin Irinotecan L-folinic | 18 Years - | UNICANCER | |
| Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer | NCT02749136 | Pancreatic Aden... | Preoperative mo... | 19 Years - | Asan Medical Center | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | NCT03504423 | Pancreatic Canc... | CPI 613, mFolfi... Folfirinox | 18 Years - 75 Years | Cornerstone Pharmaceuticals | |
| Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | NCT01821729 | Pancreatic Canc... | FOLFIRINOX Losartan Proton Beam Rad... | 18 Years - | Massachusetts General Hospital | |
| Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | NCT01523457 | Metastatic Panc... Pancreatic Canc... | Folfirinox | 18 Years - | Yale University | |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | NCT01688336 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | NCT02128100 | Pancreatic Canc... | Folfirinox Stereotactic Bo... | 18 Years - | University of Louisville | |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane | NCT03003078 | Unresectable Lo... | OncoSil™ | 18 Years - | OncoSil Medical Limited | |
| Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | NCT01523457 | Metastatic Panc... Pancreatic Canc... | Folfirinox | 18 Years - | Yale University | |
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | NCT04431258 | Pancreatic Canc... | ABTL0812 Folfirinox Placebo | 18 Years - | Ability Pharmaceuticals SL | |
| Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | NCT03825861 | Gastric Cancer | FOLFIRINOX | 18 Years - 75 Years | Instituto do Cancer do Estado de São Paulo | |
| Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | NCT05462496 | Pancreatic Canc... | Biopsy FOLFIRINOX Ciprofloxacin Metronidazole Pembrolizumab Surgical Resect... | 19 Years - | Icahn School of Medicine at Mount Sinai | |
| Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer | NCT03983057 | Pancreatic Canc... | Anti-PD-1 monoc... | 18 Years - 70 Years | Zhejiang University | |
| Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer | NCT03828799 | Metastatic Colo... | Folfirinox + re... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | NCT05360732 | Metastatic Panc... | FOLFIRINOX | 65 Years - | Fox Chase Cancer Center | |
| Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | NCT01827553 | Pancreatic Canc... | Induction chemo... Radiotherapy, 2... Chemotherapy, g... Chemotherapy wi... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | NCT05132504 | Pancreatic Duct... | Pembrolizumab Folfirinox | 18 Years - | Baylor College of Medicine | |
| Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | NCT03504423 | Pancreatic Canc... | CPI 613, mFolfi... Folfirinox | 18 Years - 75 Years | Cornerstone Pharmaceuticals | |
| A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma | NCT01839799 | Pancreatic Aden... | Gemcitabine Abraxane FOLFIRINOX Chemoradiation | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Pancreatic Locally Advanced Irresectable Cancer Ablation | NCT03690323 | Locally Advance... | Radiofrequency ... FOLFIRINOX Nab-paclitaxel ... Gemcitabine | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma | NCT06122480 | Pancreatic Duct... Oligometastatic... | FOLFIRINOX chem... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | NCT04084496 | Pancreatic Canc... | Folfirinox | 18 Years - 79 Years | Sun Yat-sen University | |
| HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | NCT03812783 | Hepatocellular ... | Hepatic arteria... Folfox Protocol Sorafenib Hepatic arteria... FOLFIRINOX | 18 Years - 75 Years | Sun Yat-sen University | |
| Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas | NCT01595321 | Pancreatic Canc... | Cyclophosphamid... PANC 10.05 pcDN... Stereotactic Bo... FOLFIRINOX | 18 Years - 76 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer | NCT04423731 | Locally Advance... Chemotherapy Ef... Borderline Rese... Pancreatectomy | Folfirinox | 18 Years - | Oslo University Hospital | |
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | NCT04431258 | Pancreatic Canc... | ABTL0812 Folfirinox Placebo | 18 Years - | Ability Pharmaceuticals SL | |
| A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | NCT01661088 | Pancreatic Canc... | FOLFIRINOX Intensity-modul... Surgical Explor... | 18 Years - | University of Michigan Rogel Cancer Center | |
| FOLFIRINOX + RT for Pancreatic Cancer | NCT01591733 | Pancreatic Canc... | FOLFIRINOX Capecitabine Short Course Ra... Surgery | 18 Years - | Massachusetts General Hospital | |
| Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | NCT03484299 | Pancreas Cancer | Irreversible El... Gemcitabine FOLFIRINOX | 18 Years - | University of Louisville | |
| FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | NCT03042780 | Gastro-enteropa... Pancreatic Canc... Neuroendocrine ... Islet Cell Carc... | FOLFIRINOX Granulocyte col... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | NCT05065801 | Metastatic Panc... | GABRINOX FOLFIRINOX | 18 Years - 75 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| A Phase II Study of Neoadjuvant FOLFIRINOX | NCT02178709 | Resectable Panc... | FOLFIRINOX | 18 Years - | Indiana University | |
| Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) | NCT05733689 | Gastroesophagea... | ctDNA Blood Tes... FLOT FOLFOX FOLFIRI FOLFIRINOX PACLITAXEL with... DOCETAXEL and I... NIVOLUMAB (alon... PEMBROLIZUMAB (... | 18 Years - | University of California, Irvine | |
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX | NCT03126435 | Metastatic Panc... Locally Advance... Pancreatic Aden... | EndoTAG-1 Gemcitabine | 18 Years - | SynCore Biotechnology Co., Ltd. | |
| Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | NCT05065801 | Metastatic Panc... | GABRINOX FOLFIRINOX | 18 Years - 75 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| FOLFIRINOX + RT for Pancreatic Cancer | NCT01591733 | Pancreatic Canc... | FOLFIRINOX Capecitabine Short Course Ra... Surgery | 18 Years - | Massachusetts General Hospital | |
| CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab | NCT05121038 | Colon Cancer Pancreas Cancer Digestive Cance... | CEND-1 Panitumumab Folfirinox | 18 Years - | University of Kansas Medical Center | |
| Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer | NCT03983057 | Pancreatic Canc... | Anti-PD-1 monoc... | 18 Years - 70 Years | Zhejiang University | |
| mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | NCT04084496 | Pancreatic Canc... | Folfirinox | 18 Years - 79 Years | Sun Yat-sen University | |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer | NCT02548169 | Pancreatic Canc... | DC Vaccine + St... | 18 Years - | Baylor Research Institute | |
| CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | NCT03699319 | Pancreatic Canc... | CPI 613 Oxaliplatin Irinotecan 5-flurouracil Folinic acid | 18 Years - 80 Years | Case Comprehensive Cancer Center | |
| NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | NCT05529940 | Resectable Panc... Neoadjuvant Che... Effects of Chem... | Folfirinox | 19 Years - 80 Years | Seoul National University Hospital | |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer | NCT02548169 | Pancreatic Canc... | DC Vaccine + St... | 18 Years - | Baylor Research Institute | |
| CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab | NCT05121038 | Colon Cancer Pancreas Cancer Digestive Cance... | CEND-1 Panitumumab Folfirinox | 18 Years - | University of Kansas Medical Center | |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | NCT03563248 | Pancreatic Canc... | FOLFIRINOX Losartan Nivolumab SBRT Surgery | 18 Years - | Massachusetts General Hospital | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer | NCT04130399 | Pancreatic Canc... Pancreatic Aden... | Stereotactic Bo... FOLFIRINOX | 18 Years - | Indiana University | |
| NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | NCT05529940 | Resectable Panc... Neoadjuvant Che... Effects of Chem... | Folfirinox | 19 Years - 80 Years | Seoul National University Hospital | |
| Systemic Chemotherapy Plus PD-1 for Metastasis ICC | NCT04398927 | ICC Metastatic Canc... | Folfirinox Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | NCT01821729 | Pancreatic Canc... | FOLFIRINOX Losartan Proton Beam Rad... | 18 Years - | Massachusetts General Hospital | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer | NCT03469375 | Pancreatic Canc... Chemotherapy Ef... Surgery--Compli... | modified-FOLFIR... | 18 Years - 85 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | NCT01836432 | Pancreatic Canc... Pancreatic Carc... Locally Advance... | FOLFIRINOX Algenpantucel-L... 5-FU Chemoradia... Gemcitabine Capecitabine Nab-Paclitaxel | 18 Years - | Lumos Pharma | |
| Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | NCT04897854 | Metastatic Panc... | Folfirinox | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | NCT04393584 | Stomach Neoplas... Gastrointestina... Docetaxel Oxaliplatin Fluoruracil Irinotecan Hydr... | Irinotecan 5-FU Leucovorin Oxaliplatin Docetaxel | 18 Years - 70 Years | Blokhin's Russian Cancer Research Center | |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | NCT03563248 | Pancreatic Canc... | FOLFIRINOX Losartan Nivolumab SBRT Surgery | 18 Years - | Massachusetts General Hospital | |
| Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | NCT02717091 | Borderline Rese... | FOLFIRINOX gemcitabine + n... | 20 Years - 75 Years | Nagoya University | |
| A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma | NCT01839799 | Pancreatic Aden... | Gemcitabine Abraxane FOLFIRINOX Chemoradiation | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | NCT03291899 | Biliary Tract C... | FOLFIRINOX | 19 Years - | King Faisal Specialist Hospital & Research Center | |
| A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | NCT01676259 | Pancreatic Duct... Pancreatic Canc... | siG12D-LODER Gemcitabine+nab... Folfirinox | 18 Years - | Silenseed Ltd | |
| Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | NCT04594772 | Pancreas Cancer | Folfirinox Gemcitabine radiation thera... Pancreatectomy | 18 Years - | University of Cincinnati | |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | NCT01688336 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer | NCT05399394 | Pancreatic Canc... | Chemotherapy Radiation | 18 Years - 75 Years | Campus Bio-Medico University | |
| Intensified Chemotherapy in CRC After Resection of Liver Metastases | NCT00208260 | Colorectal Canc... Liver Metastase... Chemotherapy | FOLFIRI FOLFOX-4 FOLFIRI-HD FOLFOX-7 FOLFIRINOX | 18 Years - 75 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | NCT05462496 | Pancreatic Canc... | Biopsy FOLFIRINOX Ciprofloxacin Metronidazole Pembrolizumab Surgical Resect... | 19 Years - | Icahn School of Medicine at Mount Sinai | |
| Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer | NCT04130399 | Pancreatic Canc... Pancreatic Aden... | Stereotactic Bo... FOLFIRINOX | 18 Years - | Indiana University | |
| Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX | NCT03590275 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | Azienda Ospedaliero, Universitaria Pisana | |
| Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma | NCT06122480 | Pancreatic Duct... Oligometastatic... | FOLFIRINOX chem... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer | NCT02749136 | Pancreatic Aden... | Preoperative mo... | 19 Years - | Asan Medical Center | |
| Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer | NCT03469375 | Pancreatic Canc... Chemotherapy Ef... Surgery--Compli... | modified-FOLFIR... | 18 Years - 85 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma | NCT04270929 | Pancreatic Aden... | FOLFIRI FOLFIRINOX TriSalus Infusi... | 18 Years - 80 Years | Roger Williams Medical Center | |
| Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | NCT02172976 | Resectable Pran... | Gemcitabine Oxaliplatin 5-Fluorouracil Irinotecan Natriumfolinate | 18 Years - 75 Years | Krankenhaus Nordwest | |
| Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer | NCT03828799 | Metastatic Colo... | Folfirinox + re... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | NCT04594772 | Pancreas Cancer | Folfirinox Gemcitabine radiation thera... Pancreatectomy | 18 Years - | University of Cincinnati | |
| Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | NCT03484299 | Pancreas Cancer | Irreversible El... Gemcitabine FOLFIRINOX | 18 Years - | University of Louisville |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
